JERUSALEM, June 2 (Xinhua) -- Israeli researchers reported success in trials of a genetic-engineering treatment for myeloma cancer, Hadassah Medical Center in Jerusalem said in a statement on Friday.
Multiple myeloma, a type of bone marrow cancer is the second most common hematological disease and is so far considered incurable.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
